Literature DB >> 12829620

Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival?

James F Markmann1, Mark Rosen, Evan S Siegelman, Michael C Soulen, Shaoping Deng, Clyde F Barker, Ali Naji.   

Abstract

There is growing interest in more widespread application of isolated islet transplantation for the treatment of type 1 diabetes; however, the sequelae of long-term islet residence within the liver are unknown. We report herein a consequence of intraportal islet transplantation, specifically the development of periportal hepatic steatosis apparently induced by the local secretion of insulin within the liver.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12829620     DOI： 10.2337/diabetes.52.7.1591

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


  40 in total

1.  Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

Authors:  Kristina I Rother; David M Harlan
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: celebrating the legacy of Paul Lacy.

Authors:  Stanley Misler
Journal:  Islets       Date:  2010 Jul-Aug       Impact factor: 2.694

3.  Current status of imaging pancreatic islets.

Authors:  John Virostko; Eric Duco Jansen; Alvin C Powers
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 4.  Assessment of islet function following islet and pancreas transplantation.

Authors:  Emily C Dy; David M Harlan; Kristina I Rother
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 5.  Facilitating physiologic self-regeneration: a step beyond islet cell replacement.

Authors:  Pleunie P M Rood; Rita Bottino; A N Balamurugan; Yong Fan; David K C Cooper; Massimo Trucco
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

Review 6.  Optimising islet engraftment is critical for successful clinical islet transplantation.

Authors:  O Korsgren; T Lundgren; M Felldin; A Foss; B Isaksson; J Permert; N H Persson; E Rafael; M Rydén; K Salmela; A Tibell; G Tufveson; B Nilsson
Journal:  Diabetologia       Date:  2007-11-27       Impact factor: 10.122

Review 7.  Cellular therapies for type 1 diabetes.

Authors:  D D Lee; E Grossman; A S Chong
Journal:  Horm Metab Res       Date:  2008-02       Impact factor: 2.936

Review 8.  Noninvasive imaging of islet transplantation and rejection.

Authors:  Jason L Gaglia
Journal:  Curr Diab Rep       Date:  2007-08       Impact factor: 4.810

Review 9.  Current challenges in islet transplantation.

Authors:  Cristiane B Leitão; Pablo Cure; Thipaporn Tharavanij; David A Baidal; Rodolfo Alejandro
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

10.  Transplantation for type I diabetes: comparison of vascularized whole-organ pancreas with isolated pancreatic islets.

Authors:  Adam Frank; Shaoping Deng; Xiaolun Huang; Ergun Velidedeoglu; Yong-Suk Bae; Chengyang Liu; Peter Abt; Robert Stephenson; Muhammad Mohiuddin; Thav Thambipillai; Eileen Markmann; Maral Palanjian; Marty Sellers; Ali Naji; Clyde F Barker; James F Markmann
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.